JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romero, J. A.
Right arrow Articles by Wurtman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romero, J. A.
Right arrow Articles by Wurtman, R. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 180, Issue 2, 277-285, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


REGIONAL EFFECTS OF L-DIHYDROXYPHENYLALANINE (L-DOPA) ON NOREPINEPHRINE METABOLISM IN RAT BRAIN

J. A. Romero 1, J. P. Chalmers 1, K. Cottman 1, L. D. Lytle 1, and R. J. Wurtman 1

1 Laboratory of Neuroendocrine Regulation and Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts

After 10 daily doses of L-dihydroxyphenylalanine (L-dopa) (100 mg/kg i.p.), rats received intracisternal tritiated norepinephrine (3H-NE) and a final dose of L-dopa five minutes later. They were killed at intervals during the next six hours and their brains were dissected into five regions (striatum, hypothalamus, brainstem, telencephalon and cerebellum) and assayed for NE, L-dopa, dopamine, 3H-NE and 3H-NE metabolites. L-Dopa caused decreases in the concentrations of O-methylated 3H-NE metabolites especially in the telencephalon, brainstem and cerebellum. As long as L-dopa was detectable in the brain, total NE pools were generally enlarged in these regions, as were dopamine levels in both the striatum and the rest of the brain. 3H-NE utilization was studied by examining three parameters: disappearance of 3H-NE, decline of 3H-NE specific activity and calculated turnover rate. Generally, these three parameters of 3H-NE kinetics were accelerated initially and then decelerated as a result of L-dopa treatment, with regional differences in magnitude and time course. In the hypothalamus, accelerated 3H-NE disappearance and turnover persisted throughout the period examined.

Submitted on May 10, 1971
Accepted on October 23, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.